Scott Gottlieb is an American physician and health policy expert. He served as the 23rd Commissioner of the U.S. Food and Drug Administration (FDA) from May 2017 to April 2019. During his tenure, Gottlieb focused on various health-related issues, including opioid addiction, tobacco regulation, and advancing medical innovation. He played a key role in shaping FDA policies, overseeing drug approvals, and implementing measures to improve public health and safety. Prior to his role as FDA Commissioner, Gottlieb had a distinguished career in healthcare policy, including serving as a Resident Fellow at the American Enterprise Institute and as a senior advisor to the Centres for Medicare and Medicaid Services. He is also a regular contributor to various media outlets, providing insights on healthcare and public health matters.
For Dr Gottlieb’s Full Bio see below.
Topics:
Unleashing the Power of Medical Innovation: Transforming Healthcare with Breakthrough Technologies and Strategies. Join Scott as he unveils the extraordinary potential of medical innovation in this captivating keynote presentation. Today, we stand on the precipice of a groundbreaking era where once-intractable diseases can be conquered. Through remarkable advancements in science, we now possess transformative tools that can not only arrest but reverse the underlying causes of previously deadly conditions. But what lies ahead in the future of medical innovation? How can we unlock the full promise of revolutionary technologies like gene therapy, digital health, artificial intelligence, and regenerative medicine? To ensure these game-changing innovations effectively reach the patients who need them most, what regulatory and reimbursement strategies must we adopt? And, perhaps most intriguingly, which key scientific breakthroughs hold the greatest potential to radically transform health outcomes and revolutionize the very delivery of medicine in the near future? In this captivating keynote, Scott Gottlieb expertly navigates these vital questions, painting a vivid portrait of the awe-inspiring possibilities that lie before us. Prepare to be inspired, informed, and captivated as Gottlieb leads us on a transformative journey toward a future where medical innovation reshapes the landscape of healthcare, unlocking unprecedented benefits for individuals and propelling us into a new era of improved well-being.
Embracing Transformative Technologies and Strategies for Improved Health OutcomesIn this keynote address, Scott explores the exciting realm of medical innovation and its potential to revolutionise healthcare. With the advent of cutting-edge tools, we now have the power to tackle once-intractable diseases and reverse their underlying causes. Join Gottlieb as he delves into the future of medicine, uncovering the promise held by transformative technologies like gene therapy, digital health, artificial intelligence, and regenerative medicine. Gain insights into the regulatory and reimbursement strategies needed to ensure these innovations reach patients and witness the scientific advances that are poised to radically transform health outcomes and revolutionise the delivery of medicine. Prepare to be inspired and informed as Gottlieb guides us on a journey towards a future where medical innovation reshapes the landscape of healthcare, empowering individuals and improving overall well-being.
These are just some of the topics that have proven valuable to customers in the past and are meant only to suggest Scott’s range and interests. For more information on these topics let us know. Scott researches each and every company he speaks to and for and the final topic is always finalised that works best for the needs of the audience.
Books: Uncontrolled Spread: Why Covid-19 Crushed Us and How We Can Defeat the Next Pandemic
Companies:
Dr. Scott Gottlieb, a renowned physician and the 23rd Commissioner of the U.S. Food and Drug Administration, brings unparalleled expertise to the stage as a keynote speaker. With a strong focus on advancing public health, he is at the forefront of developing innovative approaches to improve medical outcomes, reshape healthcare delivery, and enhance consumer choice and safety. Dr. Gottlieb serves on the boards of prestigious companies like Pfizer Inc. and Illumina, Inc., while also being a resident fellow at the American Enterprise Institute and a partner at the esteemed venture capital firm New Enterprise Associates.
Recognised as an aggressive advocate for patient health, healthcare access, and innovation, Dr. Gottlieb’s tenure as FDA Commissioner was marked by historic advances in policy and a remarkable number of approvals for novel drugs, medical devices, and generic medicines. Under his leadership, the FDA spearheaded modern and effective frameworks for overseeing cutting-edge technologies such as gene therapies, regenerative medicines, targeted drugs, and digital health devices. Notably, the FDA implemented crucial reforms to standardize drug reviews, enhance post-market data collection, and leverage real-world evidence. Driven by a commitment to reducing death and disease from tobacco, improving food safety, and tackling addiction crises, his policies have had a transformative impact.
With a wealth of experience, Dr. Gottlieb previously served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs and as a Senior Adviser to the Administrator of the Centers for Medicare and Medicaid Services. His contributions to advancing healthcare quality and the effective utilization of new medical technologies have been widely recognized and published in leading medical journals and prominent media outlets like The Wall Street Journal, The New York Times, and The Washington Post. A regular CNBC contributor, he shares valuable insights on healthcare matters.
Dr. Gottlieb’s remarkable achievements have earned him numerous accolades, including Fortune Magazine’s recognition as one of the “World’s 50 Greatest Leaders” in 2018 and 2019. Modern Healthcare consistently named him the “Most Influential Physician Executive and Leader,” and Time magazine included him in their list of the “50 People Transforming Healthcare in 2018.” As an author, he provides crucial perspectives in his book “Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic.”
Ensure a captivating and informative keynote experience by booking Dr. Scott Gottlieb as your speaker. With his deep industry knowledge and visionary approach, he will deliver engaging insights that shape the future of healthcare. Contact us now to secure Dr. Gottlieb for your event and unlock the transformative power of his expertise.
Dr. Scott Gottlieb, a renowned physician and the 23rd Commissioner of the U.S. Food and Drug Administration, brings unparalleled expertise to the stage as a keynote speaker. With a strong focus on advancing public health, he is at the forefront of developing innovative approaches to improve medical outcomes, reshape healthcare delivery, and enhance consumer choice and safety. Dr. Gottlieb serves on the boards of prestigious companies like Pfizer Inc. and Illumina, Inc., while also being a resident fellow at the American Enterprise Institute and a partner at the esteemed venture capital firm New Enterprise Associates.
Recognised as an aggressive advocate for patient health, healthcare access, and innovation, Dr. Gottlieb’s tenure as FDA Commissioner was marked by historic advances in policy and a remarkable number of approvals for novel drugs, medical devices, and generic medicines. Under his leadership, the FDA spearheaded modern and effective frameworks for overseeing cutting-edge technologies such as gene therapies, regenerative medicines, targeted drugs, and digital health devices. Notably, the FDA implemented crucial reforms to standardize drug reviews, enhance post-market data collection, and leverage real-world evidence. Driven by a commitment to reducing death and disease from tobacco, improving food safety, and tackling addiction crises, his policies have had a transformative impact.
With a wealth of experience, Dr. Gottlieb previously served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs and as a Senior Adviser to the Administrator of the Centers for Medicare and Medicaid Services. His contributions to advancing healthcare quality and the effective utilization of new medical technologies have been widely recognized and published in leading medical journals and prominent media outlets like The Wall Street Journal, The New York Times, and The Washington Post. A regular CNBC contributor, he shares valuable insights on healthcare matters.
Dr. Gottlieb’s remarkable achievements have earned him numerous accolades, including Fortune Magazine’s recognition as one of the “World’s 50 Greatest Leaders” in 2018 and 2019. Modern Healthcare consistently named him the “Most Influential Physician Executive and Leader,” and Time magazine included him in their list of the “50 People Transforming Healthcare in 2018.” As an author, he provides crucial perspectives in his book “Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic.”
Ensure a captivating and informative keynote experience by booking Dr. Scott Gottlieb as your speaker. With his deep industry knowledge and visionary approach, he will deliver engaging insights that shape the future of healthcare. Contact us now to secure Dr. Gottlieb for your event and unlock the transformative power of his expertise.
For more information on this speaker, contact Oration Speakers directly.
© 2024 Oration Speakers. Terms of Service Privacy Policy
